复方GC提取物抗心律失常的药效学及机理研究
|
摘要
目的:心律失常是多种心脏病严重的症状表现及致死的主要原因之一。通过探讨复方GC提取物的抗心律失常作用,并探索其作用机理,为复方GC提取物创新药物的研究提供药理学依据。
方法:实验采用药物诱发心律失常动物模型研究复方GC提取物抗心律失常作用。观察复方GC提取物对氯仿诱发小鼠室颤的预防作用,采用乌头碱诱发小鼠、大鼠心律失常模型;氯化钙、氯化钡、垂体后叶素诱发大鼠心律失常模型;毒毛花苷K诱发豚鼠心律失常模型,记录出现心律失常的潜伏时间及持续时间。采用拮抗肾上腺素及乙酰胆碱诱发大鼠心律失常的作用,阐明其通过调整心脏交感神经和迷走神经功能而缓解心律失常的作用机理。采用邻苯三酚法测定垂体后叶素诱发心律失常小鼠心脏超氧化物歧化酶(SOD)活性及硫代巴比妥酸(TBA)法测定过氧化脂质(LPO)含量,以揭示复方GC提取物抗心肌氧化损伤的机理;采用一氧化氮合酶(NOS)及一氧化氮(NO)试剂盒测定垂体后叶素诱发心律失常小鼠心脏及血清NOS活性及NO含量以揭示复方GC提取物扩张血管,改善心肌血流量的作用机理。所有实验数据均SPSS 13.0 for Windows统计分析软件分析处理,数据用(?)±s表示。
结果:复方GC提取物对氯仿诱发小鼠室颤,乌头碱诱发小鼠心律失常,乌头碱、肾上腺素、垂体后叶素诱发大鼠心律失常及毒毛花苷K诱发豚鼠心律失常均有较好的预防作用,药效呈浓度依赖性;对乙酰胆碱诱发大鼠心动过缓有一定拮抗作用;对氯化钙、氯化钡诱发的大鼠心律失常效果较差。作用机理研究表明复方GC提取物能通过调整心脏交感神经和迷走神经功能而缓解心律失常,并升高心律失常小鼠心脏及血清SOD及NOS活性,降低LPO含量及增加NO含量。
结论:复方GC提取物具有抗实验性心律失常作用,且有一定的量效关系。其机理可能与调整心脏交感神经和迷走神经功能、抗心肌氧自由基损伤,扩张心肌组织血管,增加心肌血流量及改善循环有关。
Objective: Cardiac arrhythmia is serious symptom in the heart diseases and one of the main dead reasons.In order to study GC compound, we did research on the antiarrhythmic action and the mechanism.
Methods: To investigate the protective effects of GC compound on experimental arrhythmia, arrhythmic animal models were established by different drugs. The preventive effects of ventricular fibrillation produced by chloroform inhalation in mice were observed. Through the arrhythmic rats&mice models established by aconitine, the antiarrhythmic effects of GC compound were evaluated. Making the arrhythmia rat models with alcium chloride, barium chloride and pituitrin respectively.The effects on arrhythmic model of Guinea pig produced by strophantin K were studied. The evaluating indicators were latent time & duration of cardiac arrhythmia. We investigated the effects of GC compound on arrhythmic rats established by adrenaline and acetylcholine (Ach) respectively to clarify the mechanism through adjusting the function of heart sympathetic nerve & pneumogastric nerve. Lipid peroxidation (LPO) content was measured with thiobarbituric acid chromatometry and the method of pyrograllol autoxidation was used to determine superoxide dismutase (SOD) .We examined the content of nitric oxide (NO) and the activity of nitric oxide synthase (NOS) in serum and cardiac muscle. Through these researches, the function of GC compound on the anoxemia of cardiac muscle and free radical were investigated. All data were processed by SPSS13. 0 for Windows and presentation of experiment results in (x|-)±s.
Results: The effects of GC compound on five different experimental models of arrhythmia are obvious and concentration dependent, except calcium chloride and barium chloride.It can increase the activities of SOD and NOS, improve the NO concentration and decrease LPO level.
Conclusion : It has been discovered in experimental researches that GC compound has antiarrhythmia effects which displays certain dosage-effect relationship. Its mechanism may be associated with adjusting the function of heart sympathetic nerve & pneumogastric nerve, eliminating free radical, dilating blood vessel and improving microcirculation.
方法:实验采用药物诱发心律失常动物模型研究复方GC提取物抗心律失常作用。观察复方GC提取物对氯仿诱发小鼠室颤的预防作用,采用乌头碱诱发小鼠、大鼠心律失常模型;氯化钙、氯化钡、垂体后叶素诱发大鼠心律失常模型;毒毛花苷K诱发豚鼠心律失常模型,记录出现心律失常的潜伏时间及持续时间。采用拮抗肾上腺素及乙酰胆碱诱发大鼠心律失常的作用,阐明其通过调整心脏交感神经和迷走神经功能而缓解心律失常的作用机理。采用邻苯三酚法测定垂体后叶素诱发心律失常小鼠心脏超氧化物歧化酶(SOD)活性及硫代巴比妥酸(TBA)法测定过氧化脂质(LPO)含量,以揭示复方GC提取物抗心肌氧化损伤的机理;采用一氧化氮合酶(NOS)及一氧化氮(NO)试剂盒测定垂体后叶素诱发心律失常小鼠心脏及血清NOS活性及NO含量以揭示复方GC提取物扩张血管,改善心肌血流量的作用机理。所有实验数据均SPSS 13.0 for Windows统计分析软件分析处理,数据用(?)±s表示。
结果:复方GC提取物对氯仿诱发小鼠室颤,乌头碱诱发小鼠心律失常,乌头碱、肾上腺素、垂体后叶素诱发大鼠心律失常及毒毛花苷K诱发豚鼠心律失常均有较好的预防作用,药效呈浓度依赖性;对乙酰胆碱诱发大鼠心动过缓有一定拮抗作用;对氯化钙、氯化钡诱发的大鼠心律失常效果较差。作用机理研究表明复方GC提取物能通过调整心脏交感神经和迷走神经功能而缓解心律失常,并升高心律失常小鼠心脏及血清SOD及NOS活性,降低LPO含量及增加NO含量。
结论:复方GC提取物具有抗实验性心律失常作用,且有一定的量效关系。其机理可能与调整心脏交感神经和迷走神经功能、抗心肌氧自由基损伤,扩张心肌组织血管,增加心肌血流量及改善循环有关。
Objective: Cardiac arrhythmia is serious symptom in the heart diseases and one of the main dead reasons.In order to study GC compound, we did research on the antiarrhythmic action and the mechanism.
Methods: To investigate the protective effects of GC compound on experimental arrhythmia, arrhythmic animal models were established by different drugs. The preventive effects of ventricular fibrillation produced by chloroform inhalation in mice were observed. Through the arrhythmic rats&mice models established by aconitine, the antiarrhythmic effects of GC compound were evaluated. Making the arrhythmia rat models with alcium chloride, barium chloride and pituitrin respectively.The effects on arrhythmic model of Guinea pig produced by strophantin K were studied. The evaluating indicators were latent time & duration of cardiac arrhythmia. We investigated the effects of GC compound on arrhythmic rats established by adrenaline and acetylcholine (Ach) respectively to clarify the mechanism through adjusting the function of heart sympathetic nerve & pneumogastric nerve. Lipid peroxidation (LPO) content was measured with thiobarbituric acid chromatometry and the method of pyrograllol autoxidation was used to determine superoxide dismutase (SOD) .We examined the content of nitric oxide (NO) and the activity of nitric oxide synthase (NOS) in serum and cardiac muscle. Through these researches, the function of GC compound on the anoxemia of cardiac muscle and free radical were investigated. All data were processed by SPSS13. 0 for Windows and presentation of experiment results in (x|-)±s.
Results: The effects of GC compound on five different experimental models of arrhythmia are obvious and concentration dependent, except calcium chloride and barium chloride.It can increase the activities of SOD and NOS, improve the NO concentration and decrease LPO level.
Conclusion : It has been discovered in experimental researches that GC compound has antiarrhythmia effects which displays certain dosage-effect relationship. Its mechanism may be associated with adjusting the function of heart sympathetic nerve & pneumogastric nerve, eliminating free radical, dilating blood vessel and improving microcirculation.
引文
[1]Richter S,Duray G,Gronefeld G,et al.Prevention of sudden cardiac death:lessons from recent controlled trials[J].Circ J,2005,69(6):625-629.
[2]蒋文平.膜离子通道与心律失常[J].中华心血管病杂志,2002,39(4):198-199.
[3]戴德哉.诱发心律失常的离子通道病变特征、类型和治疗药[J].药学进展,1998,22(3):148-152.
[4]阎升.心脏氯离子通道[J].现代诊断与治疗,1996,7(5):306-368.
[5]王方正.心律失常的研究现状[J].中国循环杂志,2001,16(6):403.
[6]Cooke L,Muntz KH.Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart[J].J Pharmacol Exp Ther,1994,269:351-357.
[7]Engelhardt S,Bohm M,Bardmann K,et al.Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions:progressive reduction of beta 1-adrenergic receptor mRNA in heart failure[J].J Am Coll Cardiol,1996,27:146-154.
[8]Valette H,Delduze P,Syrota A,et al.Canine myocardial beta-adrenergic,muscarinic receptor densities after denervation:aPET study[J].J Nucl Med,1995,36:140-146.
[9]Merlet P,Caussin C,Poiseau E,et al.In vivo assessment of neurotransmitter system in cardiovascular diseases,clinical issues[J].J Nucl Med,1996,40:108-120.
[10]Mazgalev T,Dreifus LS,Michelson EL.A new mechanism for atrioventricular nodal gap-vagal modulation of conduction[J].Circulation,1989,79:417-430.
[11]Tsuji H,Fujiki A,Tani M,et al.Quantitative relationship between atrial refractoriness and the dispersion of refractoriness in atrial vulnerability[J].PACE,1992,15:403-410.
[12]林治湖,刘少稳.自主神经在阵发性心房颤动中的作用[J].中华心血管病杂志,1996,24:462-463.
[13]Kirshenbaum LA.Regulators of apoptos is in the heart:a matter of life and death[J].Can J Cardiol,1998,14(3):457-460.
[14]Luisa M,Mauro G.Molecular genetics of dilated cardomyopathy[J].Current Opinion in Cardiology,1997,12:301-309.
[15]Chen Q,Kirsch GE,Zhang D,et al.Genetic basis and molecular mechanism for idiopathic ventricular fibrillation[J].Nature,1998,392(6673):293-296.
[16]Brugada R,Tapscott T,Czernuszewicz GZ,et al.Identification of a genetic locus for familial atrial fibrillation[J].N Engl J Med,1997,336:905-911.
[17]Roden DM.Antiarrhythmic drugs:from mechanism to clinical practice[J].Heart,2000,84(3):339-346.
[18]薛玉梅,吴书林.抗心律失常药物治疗进展[J].中国处方药,2006,7(52):9-12.
[19]张玲,郝永龙,尚立霞,等.中医药治疗心律失常的研究进展[J].食品与药品,2006,8(5):5-8.
[20]鲍霞,张会平.心律失常的中医药研究进展[J].山东中医药大学学报,2003,27(3):235-238.
[21]国家药典委员会.中华人民共和国药典2005版一部[S].北京:化学工业出版社,2005:52,60,106.
[22]徐叔云,卞如濂,陈修主编.药理实验方法学[M].北京:人民卫生出版社,2003:1171.
[23]曾靖,黄玉珊,黄贤华,等.箭叶淫羊藿叶水提取液抗心律失常作用的研究[J].赣南医学院学报,2002,22(1):12-14.
[24]胡小鹰,彭国平,陈汝炎.甘草拮抗附子心律失常毒性的机理研究[J].南京中医药大学学报,1996,12(5):23-25.
[25]胡小鹰,彭国平,陈汝炎.甘草总黄酮抗心律失常作用研究[J].中草药,1996,27(12):733-735.
[26]陆凤琴,聂桂丽,刘慧颖,等.炙甘草水提液与牛磺酸合用抗乌头碱所致小鼠心律失常的实验研究[J].天津中医学院学报,2002,21(1):32-33.
[27]施新猷.现代医学实验动物学[M].北京:人民军医出版社.2000:465-466.
[28]闫润红,任晋斌,刘必旺.山茱萸抗心律失常作用的实验研究[J].山西中医,2001,17(5):52-54.
[29]陈利平,高丽萍,易军,等.益心口服液对大鼠试验性心律失常的影响[J].解放军药学学报,2006,22(4):302-304.
[30]张华敏,曹洪欣,郭书文,等.益气升陷法抗心律失常的实验研究[J].中国中医基础医学杂志,2005,11(6):420-421.
[31]刘秀华,韩福林.北豆根总碱注射液抗实验性心律失常作用[J].黑龙江医药,2000,13(3):160-162.
[32]陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1993:884.
[33]黄贤华,胡晓,潘火英,等.迎春花提取物抗心律失常作用[J].中药药理与临床,2006,22(6):47-49.
[34]陈燕萍,缪作华,黄玉萍,等.茉莉根提取物抗实验性心律失常的研究[J].中国药物与临床,2004,4(11):844-846.
[35]欧阳昌汉,吴基良,陈金和.黄芩苷抗实验性心律失常的作用[J].咸宁医学院学报,2002,16(1):7-10.
[36]Wang YX,Liu JW,Tan YH,et al.Anti-arrhythmiac action of Cycloproto-buxine-A[J].Acta Pharm J Sin,1989,10(5):389.
[37]徐礼鲜,张洪凯,李玉清,等.布吡卡因抗心律失常作用的实验研究[J].中华麻醉学杂志,1994,14(2):118-121.
[38]隋艳华,邱德文,谢春风,等.大果木姜子油抗实验性心律失常作用[J].中国中药杂志,1998,23(8):495-497.
[39]苏彦宏,李惠兰.左旋荷包牡丹碱对抗几种强心苷所致心律失常作用的比较[J].中国民族民间医药杂志,2002,(58):301-302.
[40]陆泽安,王德成,陈植和,等.普鲁托品的抗实验性心律失常作用[J].中国药学杂志,1995,30(2):81-84.
[41]夏炎兴,杨秋美,徐雯燕,等.炙甘草抗心律失常的实验研究[J].中国中医药科技,1994,1(4):25-30.
[42]陈小夏,何冰,徐苑芬,等.救必应正丁醇提取物抗心律失常和抗心肌缺血作用研究[J].中药药理与临床,_1998,14(4):22-24.
[43]曹守仪,吴海燕,周前贵.养心定悸口服液对心血管的药理作用[J].中国中西医结合杂志,1996,16(1):39-40.
[44]徐叔云.药理实验方法学[M].北京:人民卫生出版社,1991:938-940.
[45]徐远祥,王笳,徐嘉红.益气复脉合剂抗心律失常的实验研究[J].华西药学杂志,2000,15(4):283-284.
[46]王勇,唐淑洁,王丽娟.灯盏花素抗肾上腺素实验性心律失常的作用[J].中国药业,2001,10(1):30-31.
[47]邱丽萍,王丽娟,崔红霞,等.灯盏花素联合用药对肾上腺素所致心律失常的预防作用[J].齐齐哈尔医学院学报,2002,23(8):845-846.
[48]周升,符史干,许闽广,等.D-核糖对激素诱发大鼠心肌缺血和心律失常保护作用的研究[J].中国热带医学,2004,4(4):543-545.
[49]陶虹,贺弋,周永忠.参附注射液预防心动过缓的实验观察[J].宁夏医学院学报,2005,27(5):363-365.
[50]王迪生.心得快胶囊治疗药物诱发大鼠心动过缓的实验研究[J].中国实验方剂学杂志,2006,12(2):59-61.
[51]李永利,张焱.邻苯三酚自氧化法测定SOD活性[J].中国卫生检验杂志,2000,10(6):673.
[52]孙雪奇,陈齐英,别小琳.邻苯三酚自氧化法测定SOD活性中测定波长的选择[J].华西药学杂志,2004,19(5):404-405.
[53]徐叔云主编.药理实验方法学[M].北京:人民卫生出版社,2000:535-536,431-432.
[54]杨李,唐瑛,左娟,等.硫代巴比妥酸法测定血清脂质过氧化物方法的改进[J].华南国防医学杂志,2004,18(1):30-32.
[55]邓峰美,冯光,王树人.硫代巴比妥酸法测定血清脂质过氧化物方法的改进[J].生物医学工程学杂志,2001,18(4):633-637.
[56]周玖瑶,林辉,李锐,等.环维黄杨星D对心肌缺血大鼠LDH、NO、NOS及iNOS水平的影响[J].中药材,2006,29(12):1335-1337.
[57]李萍,熊凡,富青,等.参麦注射液对心肌缺血-再灌注大鼠一氧化氮合酶系统的影响[J].微循环学杂志,2005,15(3):11-13.
[58]司秋菊,王亚利,王鑫国,等.蜈蚣对心肌缺血性损伤小鼠NO 及iNOS的影响[J].山东中医杂志,2004,23(8):492-494.
[59]王培德,马学民,张慧灵,等.刺乌头碱对麻醉大鼠心电图的影响及其抗实验性心律失常作用[J].中国药理学通报,1997,13(3):263-265.
[60]杨健,罗顺德,陈怡.莲心碱醚类衍生物抗心律失常作用[J].武汉大学学报(医学版),2002,23(4):339-342.
[61]王辉,罗顺德,杨健,等.二对氯苯甲酰莲心碱对实验性心律失常的影响[J].中国药理学通报,2003,19(3):306-308.
[62]Wang YX,Tan YH,Sheng BH.Protective effect of cycloprotobuxine-A against cardiac arrhythmiac induced by oubain[J].Acta Pharm Acol Sin,1992,13(3):226.
[63]Brooks RR,Carpenter JF,Jones SM,et al.Effects of dantrolene sodium in rodent models of cardiac arrhythmia[J].Eur J Pharmacol,1989,164(3):521-530.
[64]Furukawa Y,Xue YX,Chiba S,et al.Effects of zatebradine on ouabain,two-stage coronary ligation and epinephrine-induced ventricular tachyarrhythmias[J].Eur J Pharmacol,1996,300(3):203-210.
[65]张明爽,徐长庆,王秀丽,等.槲皮素抗实验性心律失常作用的研究[J].哈尔滨医科大学学报,2007,41(2):115-118.
[66]张红雨,徐长庆,李宏霞,等.白藜芦醇抗心律失常和抗心肌缺血作用研究[J].中国药理学通报,2006,22(3):383-384.
[67]王继光,吕高虹.苦参总黄酮抗实验性心律失常作用的研究[J].中药药理与临床,2001,17(5):13-14.
[68]WANG Yong-Xiao,LIU Jin-Wen,TAN Yue-Hua,et el.Anti-arrhythmicaction of cycloprotobuxine-A[J].Actaphamacologica Sinica,1989,10(5):389.
[69]韩志君,齐晶.常用抗心律失常中药作用机制的研究进展[J].中医药信息,2007,24(2):21-23.
[70]刘宗起.常用抗心律失常中药的临床疗效评析[J].黑龙江中医药,2006,(4):53-54.
[71]李萍,康毅,刘艳霞,等.炙甘草汤注射液对正常及“阴虚”大鼠心律失常影响的实验研究[J].中药药理与临床,1994,10(4):5-8.
[72]陈修,陈维洲,曾贵云主编.心血管药理学[M].第2版,北京: 人民卫生出版杜,1997:3.
[73]方萍,臧伟进,于晓江.乙酰胆碱对心脏心室肌的作用[J].西安医科大学学报,2000,21(5):504-505.
[74]Daaka Y,Luttrell LM,hefkowitz RJ.Switching of the coupling of the β_2-adrenergic receptor to different Gproteins by protein kinase A[J].Nature,1997,390:88-91.
[75]Engelhardt S,Hein L,Wiesmann F,et al.Progressive hypertrophy and heart failure in β_1-adrenergic receptor transgenic mice[J].Proc Natl Acad Sci USA,1999,96:7059-7064.
[76]Boyett MR,Kirby MS,Orchard CH,et al.The negative inotropic effect of acetylcholine on ferret ventricular myocardium[J].J Physiol,1988,404:613-635.
[77]Iijima T,Irisawa H,Kameyama M.Membrane currents and their modification by acetylcholine in isolated single atrial cells of the guinea-pig[J].J Physiol,1985 Feb,359:485-501.
[78]McGrattan PA,Brown JH,Brown OM.Parasympathetic effects on in vivo rat heart can be regulated through an α1adrenergic receptor[J].Circ Res,1987,60:465-471.
[79]Warner MR,Levy MN.Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y[J].Circ Res,1989,65:1536-1546.
[80]Ferrari G,Agnoletti L,Comini L,et al.Oxidative stress during myocardial ischemia and heart failure[J].Eur Heart J,1998,19(suppl B):B2-B11.
[81]石冰.氧自由基与心脏缺血性损伤[J].陕西新医药,1986,15(8):87.
[82]Pallandi RT,Perry MA,Campbell TJ.roarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium:a possiblecause of reperfusion-induced arrhythmias[J].Circ Res,1987,61:50-54.
[83]Manning AS,Hearse DJ.Reperfusion-induced arrhythmias:mechanisms and prevention[J].J Mol Cell Cardiol,1984,16:497-518.
[84]Giuseppe M,Giuscppe A and Giovanni C.Role of platelet-activatingf actor in cardiovascular pathophysiology[J].Physiological Reviews,2000,80(4):1669-1699.
[85]Hess ML,Manson NH.The role of the oxygen free radical system in the calcium paradox,the oxygen-paradox and ischemia reperfusion injury[J].J Mol Cell Cardiol,1984,16(11):969-985.
[86]于冬雁,刘琼,陈念祖,等.氧自由基与心血管疾病[J].宁波大学学报(理工版).2000,13(3):116-120.
[87]Davies PF.Mechanisms involved in endothelial responses to hemedynamlc forces[J].Atheroschrosis,1997,131(Suppl):15-17.
[88]卢建敏.冠心病血管内皮功能失调与检测[J].心血管病学进展, 2000,21(6):339-342.
[89]王秀红,路方红.内皮素、一氧化氮与心血管疾病[J].中国慢性病预防与控制,2005,13(3):139-141.
[90]汤莉莉,刘剑立,傅索贞,等.一氧化氮对家兔冠状动脉阻塞后血小板活化的影响[J].中国病理生理杂志,1997,13(4):421-423
[91]Wink DA,Hanbau er I,Krishna MC.Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species[J].Proc Natl Acad Sci USA,1993,90:9813-9817.
[92]Lawson JW.Antiarrhythmic activity of some isoquinoline derivates determined by a rapid screening procedure in the mouse[M].J Pharmacol Erp Ther,1968,160:2.
[93]张宝恒,戚世祥,齐治,等.抗心律失常中草药的筛选[J].中草药,1984,15(3):43-44.
[94]汪晖,吴基良.药理学实验[M].武汉:湖北科技出版社,2002:163-164.
[95]Sawanobori T,Adaniya H,Hirano Y,et al.Effects of antiarrhythmic agents and Mg~(2+) on aconitine-induced arrhythmias[J].Jpn Heart J,1996,37(5):709-718.
[96]Wright SN.Comparison of aconitine-modified human heart (hH1) and rat skeletal(mu1) muscle Na~+ channels:an important role for external Na~+ions[J].J Physiol,2002,538(Pt3):759-771.
[97]Duan JH,Xing JL,Yang J,et al.Different firing patterns induced by veratridine and aconitine in injured dorsal root gang lion neurons[J].Acta Physiol Sin,2005,57(2):169-174.
[98]张红雨.白藜芦醇舒血管和抗心律失常作用及机制研究[D].哈尔滨医科大学硕士学位论文,2002:46-48.
[99]Levi AJ,Boyett MR,Lee CO.The cellular actions of digitalis glycoside on the heart[M].Prog Biophys Mol Biol,1994,62:1-54.
[100]吴祯久,张红英,朴惠善,等.关苍术正丁醇提取物抗心律失常作用的研究[J].中国药理与临床,1996,52(5):26-29.
[101]张红英,李丽波,李迎军,等.4-[对-(1-苯丙三氮哇)甲基]苯丙烯酸钠抗实验性心律失常的作用[J].中国药理学通报,2004,20(7):815-817.
[102]WE Cascio.Myocardial ischemia:what factors determine ar rhythmo-genesis[J].Journal Cardiovascular E lectrophysiology,2001,12(6):726-729.
[103]Edward Carmeliet.Cardiac ionic currents and acute ischemia:From Channels to Arrhythmias[J].Physiological Reviews,1999,79(3):917-1017.
[104]曹小于,郑婉云,鲁燕滨,等.离子通道研究技术的最新进展——全自动膜片钳技术[J].现代仪器,2007,13(2):47-50.
[105]黄兵,陈雷.膜片钳技术在心肌细胞药理效应研究中的应用[J].中国药学杂志,2002,37(6):406-409.
[106]李宁,吴相锋,马克娟,等.参松养心胶囊对心室肌细胞钾通道的影响[J].疑难病杂志,2007,6(3):133-137.
[107]杜智敏,邱晓红.冠心胶囊对大鼠心肌缺血的保护作用[J].中国药学杂志,2000,35(10):664-667.
[108]周承志,张道亮,王腾,等.炙甘草汤含药血清对兔心肌细胞钙电流的影响[J].北京中医药大学学报,2007,30(7):468-471.
[109]栗德林,栗明,翟铁军.芪玄益心胶囊对糖尿病大鼠缺血心室肌细胞动作电位及瞬时外向钾电流的影响[J].天津中医药,2006,23(4):327-331.
[110]晋军,黄岚,张殿新。稳心颗粒对房颤患者心房肌细胞膜钾、钙离子通道改变的影响[J].中医杂志,2007,48(2):122.
[111]张华敏.益气升陷法抗心律失常的作用机理研究[D].黑龙江中医药大学博士学位论文,2003:6-8.
[112]贾钰华,孙学刚,贾满盈,等.清心安神方治疗中老年冠心病室性早搏107例临床观察[J].中医杂志,2000,41(1):27-28.
[113]王中原,刘红.中医药治疗早搏的研究概况[J].河南中医,2000,20(6):71-72.
[114]李跃冲,魏明刚.心宁胶囊治疗快速心律失常304例临床观察[J].中医杂志,2000,41(10):608-609.
[115]齐建兴.中医药治疗缓慢性心律失常进展[J].河北中医,2001,23(9):718-720.
[1]周玉萍.中医药治疗心律失常的思路与方法[J].中医杂志,1996,37(10):624-625.
[2]宋中午,邓艳繁,牛慧玲,等.定律汤治疗心律失常68例[J].四川中医,1998,16(11):24-25.
[3]娄彬.董其美中医辨证治疗心律失常八法[J].吉林中医药,2006,26(10):11-12.
[4]吴启富,吴世群.心律失常的中医辨证治疗体会[J].中原医刊, 1990,(6):4-5.
[5]龚少愚.心律时常中医治法浅析[J].陕西中医,2005,26(4):383-384.
[6]齐建兴.中医药治疗缓慢性心律失常进展[J].河北中医,2001,23(9):718-720.
[7]赵广兰.心律失常的辨证论治[J].心血管病防治知识,2007,(8):46-47.
[8]于萍,马秀萍.中医辨证分型治疗心律失常43例[J].陕西中医,1999,20(5):215.
[9]高毅.心律失常的辨治体会[J].山东中医药大学学报,2003,27(1):37-38.
[10]周永康.辨证分型治疗心律失常体会[J].实用中医药杂志,2004,20(3):161.
[11]王立恒主编.中医病症诊疗标准[M].济南:黄河出版社,1990:第一版,135-136,153-154.
[12]国家技术监督局.中医临床诊疗术语[S].第一辑.1997:17-20.
[13]中华人民共和国卫生部.中药新药临床研究指导原则[S].第一辑.1993:41.
[14]国家中医药管理局.中医病症诊断疗效标准[S].南京:南京大学出版社,1994:19.
[15]邵兵.炙甘草汤治疗心律失常42例[J].广西中医学院学报,2004,7(1):45
[16]宗桂芬.炙甘草治疗心律失常80例疗效观察[J].中国医药导报,2005,18(4):568.
[17]李刚.炙甘草汤加减治疗心律失常66例[J].河南中医,2006,26(9):10.
[18]张宪明,王天英.炙甘草汤治疗缓慢型心律失常65例的疗效观察[J].中国医药导报,2007,4(10):72.
[19]吴红彦.生脉散防治心血管疾病的药理研究与临床应用[J].中成药,1997,19(3):39.
[20]刘学桂,高云.生脉注射液治疗心律失常20例[J].医用放射技术杂志,2005,2:56.
[21]左玉潭.生脉注射液治疗老年冠心病心律失常疗效观察[J].实用心脑肺血管病杂志,2006,14(3):226.
[22]汪宁.生脉制剂治疗心动过缓疗效观察[J].中国民康医学,2007,19(8):275.
[23]田守智,邢儒伶.参附注射液治疗缓慢型心律失常30例疗效观察[J].山西中医,2001,17(1):13-14.
[24]王瑗萍,田卫卫,尹维东.参附注射液治疗心律失常189例[J].现代中西医结合杂志,2001,10(6):508-509.
[25]杨秀荣,孙彩云.参麦注射液治疗老年冠心病合并心律失常248例分析[J].中国误诊学杂志,2007,7(21):5071-5072.
[26]王坚,李旭.安心定悸汤改善快速性心律失常患者心率、血压及血液流变指标的作用[J].中国临床康复,2006,10(47): 147-148.
[27]孙庆财,李印珊.柴胡陷胸汤加减治疗快速性室上性心律失常60例[J].社区中医药,2007,9(16):90-91.
[28]余泽琪,李树裕,苏伟青,等.稳心颗粒对冠心病快速心律失常病人的临床疗效及甲襞微循环的影响[J].中西医结合心脑血管病杂志,2007,5(6):474-476.
[29]郑素梅,宋伯良.黄芪地黄饮治疗缓慢性心律失常23例[J].中医研究,2007,20(7):33-34.
[30]刘秀坤,赵建军.麻黄附子细辛汤加减治疗缓慢性心律失常48例[J].实用中医内科杂志,2005,19(2):156-157.
[31]刘克伟.中药治疗缓慢性心率失常54例[J].云南中医中药杂志,2006,27(2):62.
[32]刘艳芳,陈保坤,耿芳.自拟温阳活血汤治疗缓慢性心率失常47例分析[J].甘肃中医,2005,18(6):16-17.
[33]魏裕红,李远梯.加味治疗缓慢性心律失常35例[J].新中医,2007,39(9):71.
[34]胡小鹰,彭国平.甘草总黄酮抗心律失常作用研究[J].中草药,1996,27(12):733-735.
[35]谢世荣,黄彩云,杨静娴,等.甘草黄酮抗实验性心律失常的作用[J].基础医学与临床,1998,18(2):72-74.
[36]黄彩云,谢世荣,杨静娴,等.甘草水提液抗实验性心律失常的作用[J].大连医科大学学报,2003,25(1):13-15.
[37]Wen YX,Mu DP.The pharmacological effects and clinical applieation of cordyceps sinensis[J].Tianjin Pharmacy,1998,10(1):47-50.
[38]王赫,周宇宏,单宏丽,等.冬虫夏草水提液对单个心室肌细胞钾通道的影响[J].中国药理学通报,2004,20(5):536-539.
[39]秦彩玲,焦艳.羌活水溶部分的抗心律失常作用[J].中药通报,1987,(12):573.
[40]路新强,胡燕,肖文彬,等.羌活提取物对实验性心律失常的保护作用[J].军事医学科学院院刊,1992,16(4):272-274.
[41]成伊竹,闪增郁,陈燕萍.羌活水溶液不同成分抗心律失常作用的比较[J].中国中医基础医学杂志,1998,4(2):43.
[42]曾靖,黄玉珊,黄贤华,等.箭叶淫羊藿叶水提取液抗心律失常作用的研究[J].赣南医学院学报,2002,22(1):12-14.
[43]黄彩云,谢世荣,黄胜英.君子兰水提液抗实验性心律失常的作用[J].医药导报,2003,22(3):154-156.
[44]陈燕萍,缪作华,黄玉萍,等.茉莉根提取物抗实验性心律失常的研究[J].中国药物与临床,2004,4(11):844-846.
[45]黄贤华,胡晓,潘火英,等.迎春花提取物抗心律失常作用[J].中药药理与临床,2006,22(6):47-49.
[46]陈奇主编.中药药理研究方法学[M].北京:人民卫生出版社,1993.67.
[47]沈雳,吴翔.大花红景天对室性心律失常防治的初步研究[J].南通医学院学报,2002,22(4):388-390.
[48]高广欲,李淑媛,王勃,等.山麦冬水溶性提取物对动物实验性心律失常的影响[J].大连医学院学报,1986,8(3):25-27.
[49]韦德慧,杨淑琴,刘菊芳,等.麦冬注射液的抗实验性心律失常和对离体心脏的作用[J].第一军医大学学报,1983,3(1):23-26.
[50]陈敏,杨正莞,朱寄天,等.麦冬总皂苷抗心律失常作用及其电生理特性[J].中国药理学报,1990,11(2):161-165.
[51]李文宏.复脉汤有效部位的提取及抗应激性心律失常的作用与作用机制研究[D].北京中医药大学博士学位论文,2004,13-14.
[52]鲁云鹤,郑培芬,张红英,等.水芹正丁醇提取物抗心律失常作用的实验研究[J].中国中医药科技,2002,9(5):292-293.
[53]陈小夏,何冰,徐苑芬,等.救必应正丁醇提取物抗心律失常和抗心肌缺血作用研究[J].中药药理与临床,1998,14(4):22-24.
[54]龚晓健,季晖,曹祺,等.人工虫草提取物抗心律失常作用的研究[J].中国药科大学学报,2001,32(3):221-223.
[55]张兰桐,任雷鸣,温进坤.山茱萸提取液抗心律失常有效部位的研究[J].中草药,2001,32(11):1004-1007.
[56]张梅,张艺,陈海红,等.附子抗心律失常有效组分研究[J].时珍国医国药,2000,11(3):193-194.
[57]董倩,尹柱汉.膜片钳技术及其在中药抗心律失常研究中的应用[J].现代中西医结合杂志,2007,16(6):853-855.
[58]Sakakibasra Y,Wasserstrom JA,Furukawa T.Characterization of the sodium current in single human atrial myocytes[J].Cric Res,1992,71(3):535.
[59]Schneider M,Proebstle T,Hombach V,HannekumA,R(u|¨)del R.Characterization of the sodium currents in isolated human cardiocytes[J].Pflugers Arch,1994,428(1):84-90.
[60]Rivolta I,Clancy CE,Tateya ma M,et al.A novel SCN5 A mutation associated with long QT-3:altered inactivation kinetics and channel dysfunction[J].Physical Genomics,2002,10(3):191-197.
[61]Shirai N,Makita N,Sasaki K,et al.A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease[J].Cardiovasc Res,2002,53(2):348-354.
[62]Benitah J P,Gomez AM,Fauconnier J,et al.Voltage gated Ca~(2+) currents in the human pathophysiologic heart:a review[J].Basic Res Cardiol,2002,97(1):111-118.
[63]Karle CA,Zitron E,Zhang,et al.Human cardiac in wardly-rectifying K~+ channel kit 2.1b is inhibited by dirct protein kinase c-dependent regulation in human isolated cardiomycocytes and in an expression system[J].Circulation,2002,106(12):1493-1499.
[64]Li GR,Feng JL,Wang ZG,et al.Comparative mechanisms of 4-aminopyridine-resistant I_(to) in human and rabbit atrial myocytes[J].A m J Physiol,1995,269(38):H463.
[65]Gross GJ,Fryer RM.Sarcole mal versus mitochondrial ATP-sensitive K~+ channel and myocardial preconditioning [J].Circ Res,1999,84(9):973-979.
[66]Olschewski A,Brau M,Olschewski H,et al.ATO-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine:possible impact on the antiarhyth mic action of lidocaine[J].Circulation,2000,93(4):656-659.
[67]Vaughan Williams EM.A classification of antiarrhythmic actions reassessed after a decade of new drugs[J].J Clin Pharmacol,1984,24:129-147.
[68]The cardiac arrhythmia suppression trial investigators prelim inary report(CAST).New Engl J Med,1989,21:406.
[69]戴德哉.离子通道,抗心律失常药及其开发前景[J].药学进展,1997,21(4):200-207.
[70]朱良.海洋新化合物CO3抗心律失常的药理学与制剂标准研究[D].中山大学博士学位论文,2003,4.
[71]赵志刚,史卫忠,王孝蓉.抗心律失常药的分类、进展及安全应用[J].临床药物治疗杂志,2007,5(3):5-9.
[72]成建国.抗心律失常药物的致心律失常作用[J].西藏医药杂志,2007,28(2):22-24.
[73]Camm AJ,Yap YG.What should we expect from the next generation of antiarrhlunic drugs?[J].J Cardiovasc Electrophysiol 1999,10(2):307-317.
[74]Roy D,Talajic M,Dorian P,et al.Amiodarone to prevent recurrence of atrial fibrillation investigators[J].N Engl Med,2000,342:913-920.
[75]Brugada P,Wellens HJ.Arrhythmogenesis of antiarrhythmic drugs[J].Am J Cardiol,1988,61(13):1108-1111.
[76]Brugada P,Brugada J,Brugada R.Arrhythmia induction by antiarrhythmic drugs[J].Pacing Clin Electrophysiol,2000,23:291-292.
[77]侯应龙.抗心律失常药物的致心律失常作用[J].中国心脏起搏与心电生理杂志,2007,21(1):14-16.
[2]蒋文平.膜离子通道与心律失常[J].中华心血管病杂志,2002,39(4):198-199.
[3]戴德哉.诱发心律失常的离子通道病变特征、类型和治疗药[J].药学进展,1998,22(3):148-152.
[4]阎升.心脏氯离子通道[J].现代诊断与治疗,1996,7(5):306-368.
[5]王方正.心律失常的研究现状[J].中国循环杂志,2001,16(6):403.
[6]Cooke L,Muntz KH.Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart[J].J Pharmacol Exp Ther,1994,269:351-357.
[7]Engelhardt S,Bohm M,Bardmann K,et al.Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions:progressive reduction of beta 1-adrenergic receptor mRNA in heart failure[J].J Am Coll Cardiol,1996,27:146-154.
[8]Valette H,Delduze P,Syrota A,et al.Canine myocardial beta-adrenergic,muscarinic receptor densities after denervation:aPET study[J].J Nucl Med,1995,36:140-146.
[9]Merlet P,Caussin C,Poiseau E,et al.In vivo assessment of neurotransmitter system in cardiovascular diseases,clinical issues[J].J Nucl Med,1996,40:108-120.
[10]Mazgalev T,Dreifus LS,Michelson EL.A new mechanism for atrioventricular nodal gap-vagal modulation of conduction[J].Circulation,1989,79:417-430.
[11]Tsuji H,Fujiki A,Tani M,et al.Quantitative relationship between atrial refractoriness and the dispersion of refractoriness in atrial vulnerability[J].PACE,1992,15:403-410.
[12]林治湖,刘少稳.自主神经在阵发性心房颤动中的作用[J].中华心血管病杂志,1996,24:462-463.
[13]Kirshenbaum LA.Regulators of apoptos is in the heart:a matter of life and death[J].Can J Cardiol,1998,14(3):457-460.
[14]Luisa M,Mauro G.Molecular genetics of dilated cardomyopathy[J].Current Opinion in Cardiology,1997,12:301-309.
[15]Chen Q,Kirsch GE,Zhang D,et al.Genetic basis and molecular mechanism for idiopathic ventricular fibrillation[J].Nature,1998,392(6673):293-296.
[16]Brugada R,Tapscott T,Czernuszewicz GZ,et al.Identification of a genetic locus for familial atrial fibrillation[J].N Engl J Med,1997,336:905-911.
[17]Roden DM.Antiarrhythmic drugs:from mechanism to clinical practice[J].Heart,2000,84(3):339-346.
[18]薛玉梅,吴书林.抗心律失常药物治疗进展[J].中国处方药,2006,7(52):9-12.
[19]张玲,郝永龙,尚立霞,等.中医药治疗心律失常的研究进展[J].食品与药品,2006,8(5):5-8.
[20]鲍霞,张会平.心律失常的中医药研究进展[J].山东中医药大学学报,2003,27(3):235-238.
[21]国家药典委员会.中华人民共和国药典2005版一部[S].北京:化学工业出版社,2005:52,60,106.
[22]徐叔云,卞如濂,陈修主编.药理实验方法学[M].北京:人民卫生出版社,2003:1171.
[23]曾靖,黄玉珊,黄贤华,等.箭叶淫羊藿叶水提取液抗心律失常作用的研究[J].赣南医学院学报,2002,22(1):12-14.
[24]胡小鹰,彭国平,陈汝炎.甘草拮抗附子心律失常毒性的机理研究[J].南京中医药大学学报,1996,12(5):23-25.
[25]胡小鹰,彭国平,陈汝炎.甘草总黄酮抗心律失常作用研究[J].中草药,1996,27(12):733-735.
[26]陆凤琴,聂桂丽,刘慧颖,等.炙甘草水提液与牛磺酸合用抗乌头碱所致小鼠心律失常的实验研究[J].天津中医学院学报,2002,21(1):32-33.
[27]施新猷.现代医学实验动物学[M].北京:人民军医出版社.2000:465-466.
[28]闫润红,任晋斌,刘必旺.山茱萸抗心律失常作用的实验研究[J].山西中医,2001,17(5):52-54.
[29]陈利平,高丽萍,易军,等.益心口服液对大鼠试验性心律失常的影响[J].解放军药学学报,2006,22(4):302-304.
[30]张华敏,曹洪欣,郭书文,等.益气升陷法抗心律失常的实验研究[J].中国中医基础医学杂志,2005,11(6):420-421.
[31]刘秀华,韩福林.北豆根总碱注射液抗实验性心律失常作用[J].黑龙江医药,2000,13(3):160-162.
[32]陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1993:884.
[33]黄贤华,胡晓,潘火英,等.迎春花提取物抗心律失常作用[J].中药药理与临床,2006,22(6):47-49.
[34]陈燕萍,缪作华,黄玉萍,等.茉莉根提取物抗实验性心律失常的研究[J].中国药物与临床,2004,4(11):844-846.
[35]欧阳昌汉,吴基良,陈金和.黄芩苷抗实验性心律失常的作用[J].咸宁医学院学报,2002,16(1):7-10.
[36]Wang YX,Liu JW,Tan YH,et al.Anti-arrhythmiac action of Cycloproto-buxine-A[J].Acta Pharm J Sin,1989,10(5):389.
[37]徐礼鲜,张洪凯,李玉清,等.布吡卡因抗心律失常作用的实验研究[J].中华麻醉学杂志,1994,14(2):118-121.
[38]隋艳华,邱德文,谢春风,等.大果木姜子油抗实验性心律失常作用[J].中国中药杂志,1998,23(8):495-497.
[39]苏彦宏,李惠兰.左旋荷包牡丹碱对抗几种强心苷所致心律失常作用的比较[J].中国民族民间医药杂志,2002,(58):301-302.
[40]陆泽安,王德成,陈植和,等.普鲁托品的抗实验性心律失常作用[J].中国药学杂志,1995,30(2):81-84.
[41]夏炎兴,杨秋美,徐雯燕,等.炙甘草抗心律失常的实验研究[J].中国中医药科技,1994,1(4):25-30.
[42]陈小夏,何冰,徐苑芬,等.救必应正丁醇提取物抗心律失常和抗心肌缺血作用研究[J].中药药理与临床,_1998,14(4):22-24.
[43]曹守仪,吴海燕,周前贵.养心定悸口服液对心血管的药理作用[J].中国中西医结合杂志,1996,16(1):39-40.
[44]徐叔云.药理实验方法学[M].北京:人民卫生出版社,1991:938-940.
[45]徐远祥,王笳,徐嘉红.益气复脉合剂抗心律失常的实验研究[J].华西药学杂志,2000,15(4):283-284.
[46]王勇,唐淑洁,王丽娟.灯盏花素抗肾上腺素实验性心律失常的作用[J].中国药业,2001,10(1):30-31.
[47]邱丽萍,王丽娟,崔红霞,等.灯盏花素联合用药对肾上腺素所致心律失常的预防作用[J].齐齐哈尔医学院学报,2002,23(8):845-846.
[48]周升,符史干,许闽广,等.D-核糖对激素诱发大鼠心肌缺血和心律失常保护作用的研究[J].中国热带医学,2004,4(4):543-545.
[49]陶虹,贺弋,周永忠.参附注射液预防心动过缓的实验观察[J].宁夏医学院学报,2005,27(5):363-365.
[50]王迪生.心得快胶囊治疗药物诱发大鼠心动过缓的实验研究[J].中国实验方剂学杂志,2006,12(2):59-61.
[51]李永利,张焱.邻苯三酚自氧化法测定SOD活性[J].中国卫生检验杂志,2000,10(6):673.
[52]孙雪奇,陈齐英,别小琳.邻苯三酚自氧化法测定SOD活性中测定波长的选择[J].华西药学杂志,2004,19(5):404-405.
[53]徐叔云主编.药理实验方法学[M].北京:人民卫生出版社,2000:535-536,431-432.
[54]杨李,唐瑛,左娟,等.硫代巴比妥酸法测定血清脂质过氧化物方法的改进[J].华南国防医学杂志,2004,18(1):30-32.
[55]邓峰美,冯光,王树人.硫代巴比妥酸法测定血清脂质过氧化物方法的改进[J].生物医学工程学杂志,2001,18(4):633-637.
[56]周玖瑶,林辉,李锐,等.环维黄杨星D对心肌缺血大鼠LDH、NO、NOS及iNOS水平的影响[J].中药材,2006,29(12):1335-1337.
[57]李萍,熊凡,富青,等.参麦注射液对心肌缺血-再灌注大鼠一氧化氮合酶系统的影响[J].微循环学杂志,2005,15(3):11-13.
[58]司秋菊,王亚利,王鑫国,等.蜈蚣对心肌缺血性损伤小鼠NO 及iNOS的影响[J].山东中医杂志,2004,23(8):492-494.
[59]王培德,马学民,张慧灵,等.刺乌头碱对麻醉大鼠心电图的影响及其抗实验性心律失常作用[J].中国药理学通报,1997,13(3):263-265.
[60]杨健,罗顺德,陈怡.莲心碱醚类衍生物抗心律失常作用[J].武汉大学学报(医学版),2002,23(4):339-342.
[61]王辉,罗顺德,杨健,等.二对氯苯甲酰莲心碱对实验性心律失常的影响[J].中国药理学通报,2003,19(3):306-308.
[62]Wang YX,Tan YH,Sheng BH.Protective effect of cycloprotobuxine-A against cardiac arrhythmiac induced by oubain[J].Acta Pharm Acol Sin,1992,13(3):226.
[63]Brooks RR,Carpenter JF,Jones SM,et al.Effects of dantrolene sodium in rodent models of cardiac arrhythmia[J].Eur J Pharmacol,1989,164(3):521-530.
[64]Furukawa Y,Xue YX,Chiba S,et al.Effects of zatebradine on ouabain,two-stage coronary ligation and epinephrine-induced ventricular tachyarrhythmias[J].Eur J Pharmacol,1996,300(3):203-210.
[65]张明爽,徐长庆,王秀丽,等.槲皮素抗实验性心律失常作用的研究[J].哈尔滨医科大学学报,2007,41(2):115-118.
[66]张红雨,徐长庆,李宏霞,等.白藜芦醇抗心律失常和抗心肌缺血作用研究[J].中国药理学通报,2006,22(3):383-384.
[67]王继光,吕高虹.苦参总黄酮抗实验性心律失常作用的研究[J].中药药理与临床,2001,17(5):13-14.
[68]WANG Yong-Xiao,LIU Jin-Wen,TAN Yue-Hua,et el.Anti-arrhythmicaction of cycloprotobuxine-A[J].Actaphamacologica Sinica,1989,10(5):389.
[69]韩志君,齐晶.常用抗心律失常中药作用机制的研究进展[J].中医药信息,2007,24(2):21-23.
[70]刘宗起.常用抗心律失常中药的临床疗效评析[J].黑龙江中医药,2006,(4):53-54.
[71]李萍,康毅,刘艳霞,等.炙甘草汤注射液对正常及“阴虚”大鼠心律失常影响的实验研究[J].中药药理与临床,1994,10(4):5-8.
[72]陈修,陈维洲,曾贵云主编.心血管药理学[M].第2版,北京: 人民卫生出版杜,1997:3.
[73]方萍,臧伟进,于晓江.乙酰胆碱对心脏心室肌的作用[J].西安医科大学学报,2000,21(5):504-505.
[74]Daaka Y,Luttrell LM,hefkowitz RJ.Switching of the coupling of the β_2-adrenergic receptor to different Gproteins by protein kinase A[J].Nature,1997,390:88-91.
[75]Engelhardt S,Hein L,Wiesmann F,et al.Progressive hypertrophy and heart failure in β_1-adrenergic receptor transgenic mice[J].Proc Natl Acad Sci USA,1999,96:7059-7064.
[76]Boyett MR,Kirby MS,Orchard CH,et al.The negative inotropic effect of acetylcholine on ferret ventricular myocardium[J].J Physiol,1988,404:613-635.
[77]Iijima T,Irisawa H,Kameyama M.Membrane currents and their modification by acetylcholine in isolated single atrial cells of the guinea-pig[J].J Physiol,1985 Feb,359:485-501.
[78]McGrattan PA,Brown JH,Brown OM.Parasympathetic effects on in vivo rat heart can be regulated through an α1adrenergic receptor[J].Circ Res,1987,60:465-471.
[79]Warner MR,Levy MN.Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y[J].Circ Res,1989,65:1536-1546.
[80]Ferrari G,Agnoletti L,Comini L,et al.Oxidative stress during myocardial ischemia and heart failure[J].Eur Heart J,1998,19(suppl B):B2-B11.
[81]石冰.氧自由基与心脏缺血性损伤[J].陕西新医药,1986,15(8):87.
[82]Pallandi RT,Perry MA,Campbell TJ.roarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium:a possiblecause of reperfusion-induced arrhythmias[J].Circ Res,1987,61:50-54.
[83]Manning AS,Hearse DJ.Reperfusion-induced arrhythmias:mechanisms and prevention[J].J Mol Cell Cardiol,1984,16:497-518.
[84]Giuseppe M,Giuscppe A and Giovanni C.Role of platelet-activatingf actor in cardiovascular pathophysiology[J].Physiological Reviews,2000,80(4):1669-1699.
[85]Hess ML,Manson NH.The role of the oxygen free radical system in the calcium paradox,the oxygen-paradox and ischemia reperfusion injury[J].J Mol Cell Cardiol,1984,16(11):969-985.
[86]于冬雁,刘琼,陈念祖,等.氧自由基与心血管疾病[J].宁波大学学报(理工版).2000,13(3):116-120.
[87]Davies PF.Mechanisms involved in endothelial responses to hemedynamlc forces[J].Atheroschrosis,1997,131(Suppl):15-17.
[88]卢建敏.冠心病血管内皮功能失调与检测[J].心血管病学进展, 2000,21(6):339-342.
[89]王秀红,路方红.内皮素、一氧化氮与心血管疾病[J].中国慢性病预防与控制,2005,13(3):139-141.
[90]汤莉莉,刘剑立,傅索贞,等.一氧化氮对家兔冠状动脉阻塞后血小板活化的影响[J].中国病理生理杂志,1997,13(4):421-423
[91]Wink DA,Hanbau er I,Krishna MC.Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species[J].Proc Natl Acad Sci USA,1993,90:9813-9817.
[92]Lawson JW.Antiarrhythmic activity of some isoquinoline derivates determined by a rapid screening procedure in the mouse[M].J Pharmacol Erp Ther,1968,160:2.
[93]张宝恒,戚世祥,齐治,等.抗心律失常中草药的筛选[J].中草药,1984,15(3):43-44.
[94]汪晖,吴基良.药理学实验[M].武汉:湖北科技出版社,2002:163-164.
[95]Sawanobori T,Adaniya H,Hirano Y,et al.Effects of antiarrhythmic agents and Mg~(2+) on aconitine-induced arrhythmias[J].Jpn Heart J,1996,37(5):709-718.
[96]Wright SN.Comparison of aconitine-modified human heart (hH1) and rat skeletal(mu1) muscle Na~+ channels:an important role for external Na~+ions[J].J Physiol,2002,538(Pt3):759-771.
[97]Duan JH,Xing JL,Yang J,et al.Different firing patterns induced by veratridine and aconitine in injured dorsal root gang lion neurons[J].Acta Physiol Sin,2005,57(2):169-174.
[98]张红雨.白藜芦醇舒血管和抗心律失常作用及机制研究[D].哈尔滨医科大学硕士学位论文,2002:46-48.
[99]Levi AJ,Boyett MR,Lee CO.The cellular actions of digitalis glycoside on the heart[M].Prog Biophys Mol Biol,1994,62:1-54.
[100]吴祯久,张红英,朴惠善,等.关苍术正丁醇提取物抗心律失常作用的研究[J].中国药理与临床,1996,52(5):26-29.
[101]张红英,李丽波,李迎军,等.4-[对-(1-苯丙三氮哇)甲基]苯丙烯酸钠抗实验性心律失常的作用[J].中国药理学通报,2004,20(7):815-817.
[102]WE Cascio.Myocardial ischemia:what factors determine ar rhythmo-genesis[J].Journal Cardiovascular E lectrophysiology,2001,12(6):726-729.
[103]Edward Carmeliet.Cardiac ionic currents and acute ischemia:From Channels to Arrhythmias[J].Physiological Reviews,1999,79(3):917-1017.
[104]曹小于,郑婉云,鲁燕滨,等.离子通道研究技术的最新进展——全自动膜片钳技术[J].现代仪器,2007,13(2):47-50.
[105]黄兵,陈雷.膜片钳技术在心肌细胞药理效应研究中的应用[J].中国药学杂志,2002,37(6):406-409.
[106]李宁,吴相锋,马克娟,等.参松养心胶囊对心室肌细胞钾通道的影响[J].疑难病杂志,2007,6(3):133-137.
[107]杜智敏,邱晓红.冠心胶囊对大鼠心肌缺血的保护作用[J].中国药学杂志,2000,35(10):664-667.
[108]周承志,张道亮,王腾,等.炙甘草汤含药血清对兔心肌细胞钙电流的影响[J].北京中医药大学学报,2007,30(7):468-471.
[109]栗德林,栗明,翟铁军.芪玄益心胶囊对糖尿病大鼠缺血心室肌细胞动作电位及瞬时外向钾电流的影响[J].天津中医药,2006,23(4):327-331.
[110]晋军,黄岚,张殿新。稳心颗粒对房颤患者心房肌细胞膜钾、钙离子通道改变的影响[J].中医杂志,2007,48(2):122.
[111]张华敏.益气升陷法抗心律失常的作用机理研究[D].黑龙江中医药大学博士学位论文,2003:6-8.
[112]贾钰华,孙学刚,贾满盈,等.清心安神方治疗中老年冠心病室性早搏107例临床观察[J].中医杂志,2000,41(1):27-28.
[113]王中原,刘红.中医药治疗早搏的研究概况[J].河南中医,2000,20(6):71-72.
[114]李跃冲,魏明刚.心宁胶囊治疗快速心律失常304例临床观察[J].中医杂志,2000,41(10):608-609.
[115]齐建兴.中医药治疗缓慢性心律失常进展[J].河北中医,2001,23(9):718-720.
[1]周玉萍.中医药治疗心律失常的思路与方法[J].中医杂志,1996,37(10):624-625.
[2]宋中午,邓艳繁,牛慧玲,等.定律汤治疗心律失常68例[J].四川中医,1998,16(11):24-25.
[3]娄彬.董其美中医辨证治疗心律失常八法[J].吉林中医药,2006,26(10):11-12.
[4]吴启富,吴世群.心律失常的中医辨证治疗体会[J].中原医刊, 1990,(6):4-5.
[5]龚少愚.心律时常中医治法浅析[J].陕西中医,2005,26(4):383-384.
[6]齐建兴.中医药治疗缓慢性心律失常进展[J].河北中医,2001,23(9):718-720.
[7]赵广兰.心律失常的辨证论治[J].心血管病防治知识,2007,(8):46-47.
[8]于萍,马秀萍.中医辨证分型治疗心律失常43例[J].陕西中医,1999,20(5):215.
[9]高毅.心律失常的辨治体会[J].山东中医药大学学报,2003,27(1):37-38.
[10]周永康.辨证分型治疗心律失常体会[J].实用中医药杂志,2004,20(3):161.
[11]王立恒主编.中医病症诊疗标准[M].济南:黄河出版社,1990:第一版,135-136,153-154.
[12]国家技术监督局.中医临床诊疗术语[S].第一辑.1997:17-20.
[13]中华人民共和国卫生部.中药新药临床研究指导原则[S].第一辑.1993:41.
[14]国家中医药管理局.中医病症诊断疗效标准[S].南京:南京大学出版社,1994:19.
[15]邵兵.炙甘草汤治疗心律失常42例[J].广西中医学院学报,2004,7(1):45
[16]宗桂芬.炙甘草治疗心律失常80例疗效观察[J].中国医药导报,2005,18(4):568.
[17]李刚.炙甘草汤加减治疗心律失常66例[J].河南中医,2006,26(9):10.
[18]张宪明,王天英.炙甘草汤治疗缓慢型心律失常65例的疗效观察[J].中国医药导报,2007,4(10):72.
[19]吴红彦.生脉散防治心血管疾病的药理研究与临床应用[J].中成药,1997,19(3):39.
[20]刘学桂,高云.生脉注射液治疗心律失常20例[J].医用放射技术杂志,2005,2:56.
[21]左玉潭.生脉注射液治疗老年冠心病心律失常疗效观察[J].实用心脑肺血管病杂志,2006,14(3):226.
[22]汪宁.生脉制剂治疗心动过缓疗效观察[J].中国民康医学,2007,19(8):275.
[23]田守智,邢儒伶.参附注射液治疗缓慢型心律失常30例疗效观察[J].山西中医,2001,17(1):13-14.
[24]王瑗萍,田卫卫,尹维东.参附注射液治疗心律失常189例[J].现代中西医结合杂志,2001,10(6):508-509.
[25]杨秀荣,孙彩云.参麦注射液治疗老年冠心病合并心律失常248例分析[J].中国误诊学杂志,2007,7(21):5071-5072.
[26]王坚,李旭.安心定悸汤改善快速性心律失常患者心率、血压及血液流变指标的作用[J].中国临床康复,2006,10(47): 147-148.
[27]孙庆财,李印珊.柴胡陷胸汤加减治疗快速性室上性心律失常60例[J].社区中医药,2007,9(16):90-91.
[28]余泽琪,李树裕,苏伟青,等.稳心颗粒对冠心病快速心律失常病人的临床疗效及甲襞微循环的影响[J].中西医结合心脑血管病杂志,2007,5(6):474-476.
[29]郑素梅,宋伯良.黄芪地黄饮治疗缓慢性心律失常23例[J].中医研究,2007,20(7):33-34.
[30]刘秀坤,赵建军.麻黄附子细辛汤加减治疗缓慢性心律失常48例[J].实用中医内科杂志,2005,19(2):156-157.
[31]刘克伟.中药治疗缓慢性心率失常54例[J].云南中医中药杂志,2006,27(2):62.
[32]刘艳芳,陈保坤,耿芳.自拟温阳活血汤治疗缓慢性心率失常47例分析[J].甘肃中医,2005,18(6):16-17.
[33]魏裕红,李远梯.加味治疗缓慢性心律失常35例[J].新中医,2007,39(9):71.
[34]胡小鹰,彭国平.甘草总黄酮抗心律失常作用研究[J].中草药,1996,27(12):733-735.
[35]谢世荣,黄彩云,杨静娴,等.甘草黄酮抗实验性心律失常的作用[J].基础医学与临床,1998,18(2):72-74.
[36]黄彩云,谢世荣,杨静娴,等.甘草水提液抗实验性心律失常的作用[J].大连医科大学学报,2003,25(1):13-15.
[37]Wen YX,Mu DP.The pharmacological effects and clinical applieation of cordyceps sinensis[J].Tianjin Pharmacy,1998,10(1):47-50.
[38]王赫,周宇宏,单宏丽,等.冬虫夏草水提液对单个心室肌细胞钾通道的影响[J].中国药理学通报,2004,20(5):536-539.
[39]秦彩玲,焦艳.羌活水溶部分的抗心律失常作用[J].中药通报,1987,(12):573.
[40]路新强,胡燕,肖文彬,等.羌活提取物对实验性心律失常的保护作用[J].军事医学科学院院刊,1992,16(4):272-274.
[41]成伊竹,闪增郁,陈燕萍.羌活水溶液不同成分抗心律失常作用的比较[J].中国中医基础医学杂志,1998,4(2):43.
[42]曾靖,黄玉珊,黄贤华,等.箭叶淫羊藿叶水提取液抗心律失常作用的研究[J].赣南医学院学报,2002,22(1):12-14.
[43]黄彩云,谢世荣,黄胜英.君子兰水提液抗实验性心律失常的作用[J].医药导报,2003,22(3):154-156.
[44]陈燕萍,缪作华,黄玉萍,等.茉莉根提取物抗实验性心律失常的研究[J].中国药物与临床,2004,4(11):844-846.
[45]黄贤华,胡晓,潘火英,等.迎春花提取物抗心律失常作用[J].中药药理与临床,2006,22(6):47-49.
[46]陈奇主编.中药药理研究方法学[M].北京:人民卫生出版社,1993.67.
[47]沈雳,吴翔.大花红景天对室性心律失常防治的初步研究[J].南通医学院学报,2002,22(4):388-390.
[48]高广欲,李淑媛,王勃,等.山麦冬水溶性提取物对动物实验性心律失常的影响[J].大连医学院学报,1986,8(3):25-27.
[49]韦德慧,杨淑琴,刘菊芳,等.麦冬注射液的抗实验性心律失常和对离体心脏的作用[J].第一军医大学学报,1983,3(1):23-26.
[50]陈敏,杨正莞,朱寄天,等.麦冬总皂苷抗心律失常作用及其电生理特性[J].中国药理学报,1990,11(2):161-165.
[51]李文宏.复脉汤有效部位的提取及抗应激性心律失常的作用与作用机制研究[D].北京中医药大学博士学位论文,2004,13-14.
[52]鲁云鹤,郑培芬,张红英,等.水芹正丁醇提取物抗心律失常作用的实验研究[J].中国中医药科技,2002,9(5):292-293.
[53]陈小夏,何冰,徐苑芬,等.救必应正丁醇提取物抗心律失常和抗心肌缺血作用研究[J].中药药理与临床,1998,14(4):22-24.
[54]龚晓健,季晖,曹祺,等.人工虫草提取物抗心律失常作用的研究[J].中国药科大学学报,2001,32(3):221-223.
[55]张兰桐,任雷鸣,温进坤.山茱萸提取液抗心律失常有效部位的研究[J].中草药,2001,32(11):1004-1007.
[56]张梅,张艺,陈海红,等.附子抗心律失常有效组分研究[J].时珍国医国药,2000,11(3):193-194.
[57]董倩,尹柱汉.膜片钳技术及其在中药抗心律失常研究中的应用[J].现代中西医结合杂志,2007,16(6):853-855.
[58]Sakakibasra Y,Wasserstrom JA,Furukawa T.Characterization of the sodium current in single human atrial myocytes[J].Cric Res,1992,71(3):535.
[59]Schneider M,Proebstle T,Hombach V,HannekumA,R(u|¨)del R.Characterization of the sodium currents in isolated human cardiocytes[J].Pflugers Arch,1994,428(1):84-90.
[60]Rivolta I,Clancy CE,Tateya ma M,et al.A novel SCN5 A mutation associated with long QT-3:altered inactivation kinetics and channel dysfunction[J].Physical Genomics,2002,10(3):191-197.
[61]Shirai N,Makita N,Sasaki K,et al.A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease[J].Cardiovasc Res,2002,53(2):348-354.
[62]Benitah J P,Gomez AM,Fauconnier J,et al.Voltage gated Ca~(2+) currents in the human pathophysiologic heart:a review[J].Basic Res Cardiol,2002,97(1):111-118.
[63]Karle CA,Zitron E,Zhang,et al.Human cardiac in wardly-rectifying K~+ channel kit 2.1b is inhibited by dirct protein kinase c-dependent regulation in human isolated cardiomycocytes and in an expression system[J].Circulation,2002,106(12):1493-1499.
[64]Li GR,Feng JL,Wang ZG,et al.Comparative mechanisms of 4-aminopyridine-resistant I_(to) in human and rabbit atrial myocytes[J].A m J Physiol,1995,269(38):H463.
[65]Gross GJ,Fryer RM.Sarcole mal versus mitochondrial ATP-sensitive K~+ channel and myocardial preconditioning [J].Circ Res,1999,84(9):973-979.
[66]Olschewski A,Brau M,Olschewski H,et al.ATO-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine:possible impact on the antiarhyth mic action of lidocaine[J].Circulation,2000,93(4):656-659.
[67]Vaughan Williams EM.A classification of antiarrhythmic actions reassessed after a decade of new drugs[J].J Clin Pharmacol,1984,24:129-147.
[68]The cardiac arrhythmia suppression trial investigators prelim inary report(CAST).New Engl J Med,1989,21:406.
[69]戴德哉.离子通道,抗心律失常药及其开发前景[J].药学进展,1997,21(4):200-207.
[70]朱良.海洋新化合物CO3抗心律失常的药理学与制剂标准研究[D].中山大学博士学位论文,2003,4.
[71]赵志刚,史卫忠,王孝蓉.抗心律失常药的分类、进展及安全应用[J].临床药物治疗杂志,2007,5(3):5-9.
[72]成建国.抗心律失常药物的致心律失常作用[J].西藏医药杂志,2007,28(2):22-24.
[73]Camm AJ,Yap YG.What should we expect from the next generation of antiarrhlunic drugs?[J].J Cardiovasc Electrophysiol 1999,10(2):307-317.
[74]Roy D,Talajic M,Dorian P,et al.Amiodarone to prevent recurrence of atrial fibrillation investigators[J].N Engl Med,2000,342:913-920.
[75]Brugada P,Wellens HJ.Arrhythmogenesis of antiarrhythmic drugs[J].Am J Cardiol,1988,61(13):1108-1111.
[76]Brugada P,Brugada J,Brugada R.Arrhythmia induction by antiarrhythmic drugs[J].Pacing Clin Electrophysiol,2000,23:291-292.
[77]侯应龙.抗心律失常药物的致心律失常作用[J].中国心脏起搏与心电生理杂志,2007,21(1):14-16.